title: Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.
abstract: During viral infection, effector CD8 T cells contract to form a population of protective memory cells that is maintained by IL-7 and IL-15. The mechanisms that control effector cell death during infection are poorly understood. We investigated how short- and long-lived antiviral CD8 T cells differentially used the survival and cell growth pathways PI3K/AKT and JAK/STAT5. In response to IL-15, long-lived memory precursor cells activated AKT significantly better than short-lived effector cells. However, constitutive AKT activation did not enhance memory CD8 T-cell survival but rather repressed IL-7 and IL-15 receptor expression, STAT5 phosphorylation, and BCL2 expression. Conversely, constitutive STAT5 activation profoundly enhanced effector and memory CD8 T-cell survival and augmented homeostatic proliferation, AKT activation, and BCL2 expression. Taken together, these data illustrate that effector and memory cell viability depends on properly balanced PI3K/AKT signaling and the maintenance of STAT5 signaling.
authors.affiliation: Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
authors.forename: Timothy W
authors.initials: TW
authors.lastname: Hand
authors.forename: Weiguo
authors.initials: W
authors.lastname: Cui
authors.forename: Yong Woo
authors.initials: YW
authors.lastname: Jung
authors.forename: Esen
authors.initials: E
authors.lastname: Sefik
authors.forename: Nikhil S
authors.initials: NS
authors.lastname: Joshi
authors.forename: Anmol
authors.initials: A
authors.lastname: Chandele
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Susan M
authors.initials: SM
authors.lastname: Kaech
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000378:metabolism*; D002470:Cell Survival; D015536:Down-Regulation; D007156:Immunologic Memory; D019409:Interleukin-15 / Q000494:pharmacology; D037181:Lectins, C-Type; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology / Q000472:pathogenicity; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D008822:Mice, Transgenic; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D018121:Receptors, Cytokine / Q000378:metabolism; D011971:Receptors, Immunologic / Q000378:metabolism; D050799:STAT5 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D019409:Interleukin-15; D037181:Lectins, C-Type; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D018121:Receptors, Cytokine; D011971:Receptors, Immunologic; D050799:STAT5 Transcription Factor; C451496:Klrg1 protein, mouse
references.citation: Nat Med. 2003 May;9(5):540-7
references.pmid: 12692546
references.citation: Immunity. 2001 May;14(5):523-34
references.pmid: 11371355
references.citation: Blood. 2002 Nov 15;100(10):3698-702
references.pmid: 12393723
references.citation: J Immunol. 2003 Jan 1;170(1):210-7
references.pmid: 12496402
references.citation: J Exp Med. 2008 Mar 17;205(3):565-74
references.pmid: 18283119
references.citation: J Immunol. 2008 May 1;180(9):5935-45
references.pmid: 18424713
references.citation: Nat Immunol. 2008 May;9(5):513-21
references.pmid: 18391955
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11730-5
references.pmid: 17609371
references.citation: J Exp Med. 2002 Jun 17;195(12):1541-8
references.pmid: 12070282
references.citation: Blood. 2008 Nov 1;112(9):3704-12
references.pmid: 18689546
references.citation: J Immunol. 2006 Oct 1;177(7):4458-63
references.pmid: 16982881
references.citation: Science. 2001 Dec 7;294(5549):2186-9
references.pmid: 11691952
references.citation: Nature. 2009 Jul 2;460(7251):108-12
references.pmid: 19543266
references.citation: J Immunol. 2006 Jul 15;177(2):831-9
references.pmid: 16818737
references.citation: Blood. 2008 Feb 15;111(4):2101-11
references.pmid: 18042802
references.citation: J Immunol. 2008 Apr 15;180(8):5309-19
references.pmid: 18390712
references.citation: Nature. 1999 Jun 10;399(6736):593-7
references.pmid: 10376601
references.citation: Nat Immunol. 2004 Sep;5(9):919-26
references.pmid: 15311278
references.citation: Immunol Res. 2009;45(1):46-61
references.pmid: 18629449
references.citation: J Exp Med. 2007 Jul 9;204(7):1665-75
references.pmid: 17591857
references.citation: Immunity. 2007 Aug;27(2):281-95
references.pmid: 17723218
references.citation: Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13414-9
references.pmid: 17686974
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5610-5
references.pmid: 15044705
references.citation: J Exp Med. 2007 Jul 9;204(7):1625-36
references.pmid: 17606632
references.citation: J Immunol. 2007 Nov 15;179(10):6734-40
references.pmid: 17982063
references.citation: Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):513-33
references.pmid: 15996891
references.citation: J Immunol. 2008 Mar 1;180(5):2855-62
references.pmid: 18292507
references.citation: Nat Immunol. 2003 Dec;4(12):1191-8
references.pmid: 14625547
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13759-64
references.pmid: 12354940
references.citation: Blood. 2007 Feb 15;109(4):1678-86
references.pmid: 17038539
references.citation: Annu Rev Immunol. 2006;24:657-79
references.pmid: 16551262
references.citation: J Exp Med. 2007 Sep 3;204(9):2015-21
references.pmid: 17698591
references.citation: J Immunol. 2000 Mar 1;164(5):2533-41
references.pmid: 10679091
references.citation: J Immunol. 2006 Jan 1;176(1):507-15
references.pmid: 16365444
references.citation: J Exp Med. 2008 Mar 17;205(3):625-40
references.pmid: 18316415
references.citation: Immunity. 2009 Aug 21;31(2):296-308
references.pmid: 19664941
references.citation: Nat Immunol. 2000 Nov;1(5):426-32
references.pmid: 11062503
references.citation: J Exp Med. 2007 Jan 22;204(1):79-91
references.pmid: 17190839
references.citation: Nature. 2009 Jul 2;460(7251):103-7
references.pmid: 19494812
references.citation: Infect Immun. 2009 Sep;77(9):3894-901
references.pmid: 19528214
references.citation: Cell. 2007 Jun 29;129(7):1261-74
references.pmid: 17604717
references.citation: Nat Med. 2007 Jul;13(7):843-50
references.pmid: 17558415
references.citation: J Immunol. 2008 Feb 1;180(3):1309-15
references.pmid: 18209024
references.citation: Blood. 2009 Jun 25;113(26):6619-28
references.pmid: 19406987
references.citation: J Exp Med. 2007 Mar 19;204(3):619-31
references.pmid: 17325202
references.citation: J Immunol. 2003 Dec 1;171(11):5853-64
references.pmid: 14634095
references.citation: J Biol Chem. 2004 Feb 13;279(7):5520-7
references.pmid: 14660677
references.citation: Mol Cell Biol. 1998 Jul;18(7):3871-9
references.pmid: 9632771